Unlike patient 7 (Fig. 3c), this AML co-expressed CD34, a stem and progenitor marker characteristic of CD34+ AMLs47, for which CD34+ cells in contrast to CD34− cells have been shown to possess leukemia-propagating activity48,49. Here, CD34 is linked to leukemia.